Pricing, Profits and Progress: Pharma’s Post-COVID PrioritiesAs post-pandemic recovery begins, big pharma remains in the spotlight. Jesse Mendelsohn explores pharma’s priorities on pricing, profits and Share XPricing, Profits and Progress: Pharma’s Post-COVID Prioritieshttps://pharmaphorum.com/views-and-analysis/pricing-profits-and-progress-pharmas-post-covid-priorities/
Merck nabs $1.2 billion order for oral COVID antiviral from USThe US government has placed an order with Merck & Co to buy 1.7 million courses of its Share XMerck nabs $1.2 billion order for oral COVID antiviral from UShttps://pharmaphorum.com/news/merck-grabs-1-2-billion-order-for-oral-covid-antiviral-from-us/
FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decisionPfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal Share XFDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decisionhttps://pharmaphorum.com/news/fda-clears-pfizers-prevnar-20-for-adults-as-merck-rival-nears-decision/
Dermavant raises $200m to ease launch of Otezla rival tapinarofDermavant is in line to make some big payments to GlaxoSmithKline if its topical psoriasis drug tapinarof reaches Share XDermavant raises $200m to ease launch of Otezla rival tapinarofhttps://pharmaphorum.com/news/dermavant-raises-200m-to-ease-launch-of-otezla-rival-tapinarof/
Experts discuss the field force’s customer-centric futureThe ways in which HCPs prefer to engage with pharma has been changing for quite some time, and Share XExperts discuss the field force’s customer-centric futurehttps://pharmaphorum.com/sales-marketing/experts-discuss-the-field-forces-customer-centric-future/
FDA ends 7-year obesity drug drought, clearing Novo Nordisk’s WegovyNovo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which Share XFDA ends 7-year obesity drug drought, clearing Novo Nordisk’s Wegovyhttps://pharmaphorum.com/news/fda-ends-obesity-drug-drought/
PM Society Training: Essentials of Pharmaceutical MarketingWho will benefit? New and aspiring marketers and those wanting to refresh their marketing thinking and be fitter Share XPM Society Training: Essentials of Pharmaceutical Marketinghttps://pharmaphorum.com/events/pm-society-training-essentials-of-pharmaceutical-marketing/
Moderna ramps up EU COVID jab capacity via Lonza dealCapacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, Share XModerna ramps up EU COVID jab capacity via Lonza dealhttps://pharmaphorum.com/news/moderna-ramps-up-eu-covid-jab-capacity-via-lonza-deal/
Novartis halts three trials of Beovu eye drug on safety concernsProspects for Novartis’ ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a Share XNovartis halts three trials of Beovu eye drug on safety concernshttps://pharmaphorum.com/news/novartis-halts-three-trials-of-beovu-eye-drug-on-safety-concerns/
